Regenerative Medical Technology Group Inc. Stock Issued During Period, Value, Conversion of Units
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of units for the quarter ending 2022-12-31 was $0.00.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of units for the quarter ending 2022-09-30 was $0.00, a 100.00% decline year-over-year.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of units for the quarter ending 2022-06-30 was $0.00.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of units for the quarter ending 2022-03-31 was $251.54K.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of units for fiscal 2024 was $1.80K, a 295.82% increase from fiscal 2023.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of units for fiscal 2023 was $455.00, a 99.82% decline from fiscal 2022.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of units for fiscal 2022 was $251.54K, a 0.00% change from fiscal 2021.
- Regenerative Medical Technology Group Inc. stock issued during period, value, conversion of units for fiscal 2021 was $251.54K.
| Period end | Stock Issued During Period, Value, Conversion of Units 3 month | Stock Issued During Period, Value, Conversion of Units 12 month |
|---|---|---|
| 2024-12-31 | $1.80K 10-K · filed 2025-04-15 | |
| 2023-12-31 | $455.00 10-K · filed 2025-04-15 | |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-14 | $251.54K 10-K · filed 2023-04-14 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $251.54K derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-11-20 | $503.07K derived: sum of 4 quarters · filed 2023-11-20 |
| 2022-03-31 | $251.54K 10-Q · filed 2023-05-22 | |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-04-14 | $251.54K 10-K · filed 2023-04-14 |
| 2021-09-30 | $251.54K 10-Q · filed 2022-11-09 |